Boston Scientific Corporation (FRA:BSX)
Germany · Delayed Price · Currency is EUR 63.80
-0.80 (-1.24%)
At close: Feb 20, 2026
Boston Scientific Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2,898 | 1,853 | 1,593 | 698 | 1,041 |
Depreciation & Amortization | 1,368 | 1,269 | 1,196 | 1,136 | 1,093 |
Loss (Gain) From Sale of Assets | - | - | - | 22 | -78 |
Asset Writedown & Restructuring Costs | 46 | 386 | 58 | 132 | 370 |
Loss (Gain) From Sale of Investments | -139 | 79 | 59 | 1 | -250 |
Stock-Based Compensation | 299 | 266 | 233 | 220 | 194 |
Other Operating Activities | 308 | 44 | 134 | 322 | -149 |
Change in Accounts Receivable | -269 | -351 | -238 | -220 | -279 |
Change in Inventory | -188 | -228 | -660 | -321 | -346 |
Change in Accounts Payable | 296 | 243 | 118 | -255 | 408 |
Change in Other Net Operating Assets | -85 | -126 | 10 | -209 | -134 |
Operating Cash Flow | 4,534 | 3,435 | 2,503 | 1,526 | 1,870 |
Operating Cash Flow Growth | 31.99% | 37.23% | 64.02% | -18.40% | 24.01% |
Capital Expenditures | -876 | -790 | -711 | -588 | -554 |
Sale of Property, Plant & Equipment | - | - | - | 12 | 14 |
Cash Acquisitions | -1,593 | -4,640 | -1,811 | -1,542 | -2,258 |
Divestitures | - | - | - | 5 | 826 |
Sale (Purchase) of Intangibles | - | - | - | 70 | 82 |
Investment in Securities | -254 | -280 | -89 | -24 | 279 |
Other Investing Activities | 83 | 23 | 37 | 56 | 14 |
Investing Cash Flow | -2,640 | -5,687 | -2,574 | -2,011 | -1,597 |
Short-Term Debt Issued | - | 187 | - | - | - |
Long-Term Debt Issued | 1,558 | 2,145 | - | 3,270 | - |
Total Debt Issued | 1,558 | 2,332 | - | 3,270 | - |
Short-Term Debt Repaid | -1,791 | -504 | -4 | -251 | - |
Long-Term Debt Repaid | -258 | -25 | - | -3,184 | - |
Total Debt Repaid | -2,049 | -529 | -4 | -3,435 | - |
Net Debt Issued (Repaid) | -491 | 1,803 | -4 | -165 | - |
Issuance of Common Stock | 282 | 230 | 182 | 136 | 110 |
Preferred Dividends Paid | - | - | - | -55 | -55 |
Dividends Paid | - | - | - | -55 | -55 |
Other Financing Activities | -186 | -219 | -173 | -464 | -150 |
Financing Cash Flow | -395 | 1,814 | 5 | -548 | -95 |
Foreign Exchange Rate Adjustments | 42 | -11 | -4 | -9 | -6 |
Miscellaneous Cash Flow Adjustments | - | -1 | - | - | 1 |
Net Cash Flow | 1,541 | -450 | -70 | -1,042 | 173 |
Free Cash Flow | 3,658 | 2,645 | 1,792 | 938 | 1,316 |
Free Cash Flow Growth | 38.30% | 47.60% | 91.05% | -28.72% | 16.25% |
Free Cash Flow Margin | 18.22% | 15.79% | 12.58% | 7.40% | 11.07% |
Free Cash Flow Per Share | 2.45 | 1.78 | 1.22 | 0.65 | 0.92 |
Cash Interest Paid | 319 | 250 | 259 | 450 | 338 |
Cash Income Tax Paid | 561 | 656 | 512 | 662 | 302 |
Levered Free Cash Flow | 3,242 | 1,788 | 1,850 | 1,155 | 2,654 |
Unlevered Free Cash Flow | 3,460 | 1,978 | 2,016 | 1,449 | 2,867 |
Change in Working Capital | -246 | -462 | -770 | -1,005 | -351 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.